Abstract
Biological age-related adaptations have been shown to modulate the non-malignant cells comprising the tumor microenvironment (TME). In the current work, we studied the association between biological age and TME characteristics in patients with esophageal adenocarcinoma. We comparatively assessed intratumoral histologic stroma quantity, tumor immune cell infiltrate, and blood leukocyte and thrombocyte count in 72 patients stratified in 3 strata of biological age (younger <70 years, fit older ≥70 years, and frail older adults ≥70 years), as defined by a geriatric assessment. Frailty in older adults was predictive of decreased intratumoral stroma quantity (B = -14.66% stroma, P = 0.022) relative to tumors in chronological-age-matched fit older adults. Moreover, in comparison to younger adults, frail older adults (P = 0.032), but not fit older adults (P = 0.302), demonstrated a lower blood thrombocyte count at the time of diagnosis. Lastly, we found an increased proportion of tumors with a histologic desert TME phenotype in frail older adults. Our findings provide a biological underpinning for the clinical relevance of assessing frailty in patients with esophageal adenocarcinoma, further justifying the need for standardized geriatric assessment in geriatric cancer patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from the Bollenstreekfonds Lisse-Hillegom, the Leiden University Medical Center, the Institute for Evidence-Based Medicine in Old Age (IEMO), and the Vitality Oriented Innovations for the Lifecourse of the Ageing Society (VOILA) project. VOILA is funded by ZonMw (project number 457001001).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Medical Ethics Committee of the Leiden University Medical Center gave ethical approval for this work (ID number NL53575.058.15).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Shared senior author
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- 6CIT
- 6-item cognitive impairment test
- ADL
- activities of daily living
- BMI
- body mass index
- CCI
- Charlson Comorbidity Index
- ECM
- extracellular matrix
- GA
- geriatric assessment
- H&E
- hematoxylin and eosin
- iADL
- instrumental activities of daily living
- IQR
- interquartile range
- SASP
- senescence-associated secretory phenotype
- SD
- standard deviation
- SHIH
- stroma-high/immune-high
- SHIL
- stroma-high/immune-low
- SLIH
- stroma-low/immune-high
- SLIL
- stroma-low/immune-low
- TICI
- tumor immune cell infiltrate
- TME
- tumor microenvironment
- TSR
- tumor-stroma ratio.
